Qyuns Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 100
Employees
  • Latest Deal Type
  • Series C
  • Investors
  • 11

Qyuns General Information

Description

Developer of antibody drugs for immune diseases. The company focuses on research and development of antibody drugs for the treatment of immune-related diseases and provides clinical products for curing other diseases such as asthma and rheumatoid arthritis, enabling patients to attain an effective treatment for diseases and improve their health conditions.

Contact Information

Website
www.qyuns.net
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • No.907 Yaocheng Avenue
  • Taizhou, Jiangsu
  • China
+86 0523 0000 0000

Qyuns Timeline

2019202020212022
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Qyuns Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series C) 07-Mar-2022 00000 Completed Generating Revenue
6. Later Stage VC (Series B2) 15-Apr-2021 000.00 00000 00000 Completed Generating Revenue
5. Early Stage VC 14-Aug-2020 000.00 000.00 00000 Completed Generating Revenue
4. Early Stage VC (Series B1) 06-May-2020 00.00 Completed Generating Revenue
3. Early Stage VC (Series B) 30-Jul-2019 00.00 Completed Generating Revenue
2. Early Stage VC (Series A) 03-Jun-2016 $3.8M Completed Generating Revenue
1. Seed Round 24-Nov-2015 $3.8M $3.8M 000.00 Completed Startup
To view Qyuns’s complete valuation and funding history, request access »

Qyuns Executive Team (2)

Name Title Board Seat Contact Info
Jiwan Qiu Chief Executive Officer & Co-Founder
Guoliang Yu Ph.D Chairman & Co-Founder
To view Qyuns’s complete executive team members history, request access »

Qyuns Board Members (1)

Name Representing Role Since
Guoliang Yu Ph.D Qyuns Chairman & Co-Founder 000 0000
To view Qyuns’s complete board members history, request access »

Qyuns Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Qyuns Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Asiaview Capital Growth/Expansion Minority 000 0000 000000 0
China Merger & Acquisition Fund Growth/Expansion Minority 000 0000 000000 0
Cowin Capital Venture Capital Minority 000 0000 000000 0
Everest VC Venture Capital Minority 000 0000 000000 0
Matrix Partners China Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial